TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation

Triggering receptor expressed on myeloid cells (TREM) has been broadly studied in inflammatory disease. However, the expression and function of TREM-2 remain undiscovered in acquired cholesteatoma. The expression of TREM-2 was significantly higher in human acquired cholesteatoma than in normal skin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Huaili, Si, Yu, Li, Zhuohao, Huang, Xi, Chen, Suijun, Zheng, Yiqing, Xu, Guo, Chen, Ximing, Chen, Yubin, Liu, Yi, Xiong, Hao, Huang, Qiuhong, Liang, Maojin, Zhang, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146948/
https://www.ncbi.nlm.nih.gov/pubmed/27934908
http://dx.doi.org/10.1038/srep38761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146948/
https://www.ncbi.nlm.nih.gov/pubmed/27934908
http://dx.doi.org/10.1038/srep38761

Ejemplares similares